Evolution of a cytokine using DNA family shuffling. 1999

C C Chang, and T T Chen, and B W Cox, and G N Dawes, and W P Stemmer, and J Punnonen, and P A Patten
Maxygen, Inc., 3410 Central Expressway, Santa Clara, CA 95051, USA.

DNA shuffling of a family of over 20 human interferon-alpha (Hu-IFN-alpha) genes was used to derive variants with increased antiviral and antiproliferation activities in murine cells. A clone with 135,000-fold improved specific activity over Hu-IFN-alpha2a was obtained in the first cycle of shuffling. After a second cycle of selective shuffling, the most active clone was improved 285,000-fold relative to Hu-IFN-alpha2a and 185-fold relative to Hu-IFN-alpha1. Remarkably, the three most active clones were more active than the native murine IFN-alphas. These chimeras are derived from up to five parental genes but contained no random point mutations. These results demonstrate that diverse cytokine gene families can be used as starting material to rapidly evolve cytokines that are more active, or have superior selectivity profiles, than native cytokine genes.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D004686 Encephalomyocarditis virus The type species of CARDIOVIRUS causing encephalomyelitis and myocarditis in rodents, pigs, and monkeys. Infection in man has been reported with CNS involvement but without myocarditis. EMCV
D006224 Cricetinae A subfamily in the family MURIDAE, comprising the hamsters. Four of the more common genera are Cricetus, CRICETULUS; MESOCRICETUS; and PHODOPUS. Cricetus,Hamsters,Hamster
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral

Related Publications

C C Chang, and T T Chen, and B W Cox, and G N Dawes, and W P Stemmer, and J Punnonen, and P A Patten
January 2002, Methods in molecular biology (Clifton, N.J.),
C C Chang, and T T Chen, and B W Cox, and G N Dawes, and W P Stemmer, and J Punnonen, and P A Patten
March 1999, Nature biotechnology,
C C Chang, and T T Chen, and B W Cox, and G N Dawes, and W P Stemmer, and J Punnonen, and P A Patten
January 1998, Nature,
C C Chang, and T T Chen, and B W Cox, and G N Dawes, and W P Stemmer, and J Punnonen, and P A Patten
February 1998, Trends in biotechnology,
C C Chang, and T T Chen, and B W Cox, and G N Dawes, and W P Stemmer, and J Punnonen, and P A Patten
July 2002, Genome biology,
C C Chang, and T T Chen, and B W Cox, and G N Dawes, and W P Stemmer, and J Punnonen, and P A Patten
June 2023, Biotechnology letters,
C C Chang, and T T Chen, and B W Cox, and G N Dawes, and W P Stemmer, and J Punnonen, and P A Patten
February 2000, Gene,
C C Chang, and T T Chen, and B W Cox, and G N Dawes, and W P Stemmer, and J Punnonen, and P A Patten
January 2004, Methods in enzymology,
C C Chang, and T T Chen, and B W Cox, and G N Dawes, and W P Stemmer, and J Punnonen, and P A Patten
March 2013, Applied microbiology and biotechnology,
C C Chang, and T T Chen, and B W Cox, and G N Dawes, and W P Stemmer, and J Punnonen, and P A Patten
March 1996, Nature biotechnology,
Copied contents to your clipboard!